Always use our prescription products under medical supervision:
| Therapy Area | Brand name | Generic name | Formulation | Strength |
| Rare Diseases |
Cerezyme® | Imiglucerase | For Intravenous infusion only | 400 Units/ vial |
| Myozyme® | Alglucosidase alfa | For Intravenous infusion only | 50 mg/vial | |
| Aldurazyme® | Laronidase |
Concentrated Solution for |
2.9mg/5ml vial | |
| Fabrazyme® | Agalsidase Beta | Concentrated Solution for Intravenous Infusion Only |
35mg/ Vial | |
| Multiple Sclerosis (MS) |
Lemtrada® | Alemtuzumab | Concentrated Solution for Intravenous Infusion Only |
12mg/1.2ml vial |
| Aubagio® | Teriflunomide | Oral Tablets | 14 mg tablets, pack of 28 film coated tablets |
|
| Oncology | Jevtana® | Cabazitaxel | Concentrated Solution for Intravenous Infusion Only |
60 mg/1.5ml Vial |
Contact us
For seeking medical information, reporting adverse events and product complaints: 1800 22 2295 (toll-free)For other queries: 022-28032000
For medical information: medinfo.india@sanofi.com, customercare.chc@sanofi.com (Consumer healthcare products)
For reporting adverse events: PV.india@sanofi.com
For product complaints: ptcindia@sanofi.com
For other queries : Write here
All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.
You can email or call us between 9 AM and 5 PM on any working day (we are closed on Saturday, Sunday and public holidays). Please select IVRS option 3 for reporting adverse events.